|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Reduced levels of N-terminal-proatrial natriuretic peptide in hypertensive patients with metabolic syndrome and their relationship with left ventricular mass显示文摘 | Speranza Rubattu Sebastiano Sciarretta Giuseppino Massimo Ciavarella Vanessa Venturelli Paola De Paolis Giuliano Tocci Luciano De Biase Andrea Ferrucci Massimo Volpe | 2007 | Journal of Hypertension2007，，4： | 2 |
| 2 | HP-NAP inhibits the growth of bladder cancer in mice by activating a cytotoxic Th1 response显示文摘 | Gaia Codolo Matteo Fassan Fabio Munari Andrea Volpe Piefrancesco Bassi Massimo Rugge Francesco Pagano Mario Milco D’Elios Marina Bernard | 2012 | Cancer Immunology Immunotherapy2012，，1： | 2 |
| 3 | Olmesartan vs. Ramipril in Elderly Hypertensive Patients: Review of Data from Two Published Randomized, Double-Blind Studies显示文摘 | Stefano Omboni Ettore Malacco Jean-Michel Mallion Paolo Fabrizzi Massimo Volpe | 2014 | High Blood Pressure & Cardiovascular Prevention2014，，： | 1 |
| 4 | Markers of Inflammation and Fibrosis Are Related to Cardiovascular Damage in Hypertensive Patients with Metabolic Syndrome显示文摘 | Sebastiano Sciarretta Andrea Ferrucci Giuseppino Massimo Ciavarella Paola De Paolis Vanessa Venturelli Giuliano Tocci Luciano De Biase Speranza Rubattu Massimo Volpe | 2007 | American Journal of Hypertension2007，，7： | 1 |
| 5 | HP-NAP inhibits the growth of bladder cancer in mice by activating a cytotoxic Th1 response显示文摘 | Gaia Codolo Matteo Fassan Fabio Munari Andrea Volpe Piefrancesco Bassi Massimo Rugge Francesco Pagano Mario Milco D’Elios Marina Bernard | 2012 | Cancer Immunology Immunotherapy2012，，1： | 1 |
| 6 | Circulating biomarkers with preventive, diagnostic and prognostic implications in cardiovascular diseases显示文摘 | Allegra Battistoni Speranza Rubattu Massimo Volpe | 2011 | International Journal of Cardiology2011，，2： | 1 |
| 7 | Risk Factors and Severe Outcome in Thrombotic Microangiopathy After Allogeneic Hematopoietic Stem Cell Transplantation显示文摘 | Cornelio Uderzo Sonia Bonanomi Alessandro Busca Mila Renoldi Pierantonio Ferrari Massimo Iacobelli Giuseppe Morreale Edoardo Lanino Claudio Annaloro Aldo Della Volpe Paolo Alessandrino Daniela Longoni Franco Locatelli Haidi Sangalli Attilio Rovelli | 2006 | Transplantation2006，，： | 1 |
| 8 | Expert consensus document from the European Society of Cardiology on catheter-based renal denervation?显示文摘 | Felix Mahfoud Thomas Felix Lüscher Bert Andersson Iris Baumgartner Renata Cifkova Carlo DiMario Pieter Doevendans Robert Fagard Jean Fajadet Michel Komajda Thierry LeFèvre Chaim Lotan Horst Sievert Massimo Volpe Petr Widimsky William Wijns Bryan Williams | 2013 | European Heart Journal2013，，28： | 1 |
| 9 | Assessment of flow-mediated dilation reproducibility: a nationwide multicenter study显示文摘 | Lorenzo Ghiadoni Francesco Faita Massimo Salvetti Carlo Cordiano Almerina Biggi Massimo Puato Antonio Di Monaco Luca De Siati Massimo Volpe Giuseppe Ambrosio Vincenzo Gemignani Maria L. Muiesan Stefano Taddei Gaetano A. Lanza Francesco Cosentino | 2012 | Journal of Hypertension2012，，7： | 1 |
| 10 | Expert consensus document from the European Society of Cardiology on catheter-based renal denervation?显示文摘 | Felix Mahfoud Thomas Felix Lüscher Bert Andersson Iris Baumgartner Renata Cifkova Carlo DiMario Pieter Doevendans Robert Fagard Jean Fajadet Michel Komajda Thierry LeFèvre Chaim Lotan Horst Sievert Massimo Volpe Petr Widimsky William Wijns Bryan Williams | 2013 | European Heart Journal2013，，28： | 1 |
| 11 | p66Shc protein, oxidative stress, and cardiovascular complications of diabetes: the missing link显示文摘 | Pietro Francia Francesco Cosentino Marzia Schiavoni Yale Huang Enrico Perna Giovani G. Camici Thomas F. Lüscher Massimo Volpe | 2009 | Journal of Molecular Medicine2009，，9： | 1 |
| 12 | Role of induced pluripotent stem cells in diagnostic cardiology显示文摘Ethical concerns about stem cell-based research have delayed important advances in many areas of medicine,including cardiology.The introduction of induced pluripotent stem cells(iPSCs)has supplanted the need to use human stem cells for most purposes,thus eliminating all ethical controversies.Since then,many new avenues have been opened in cardiology research,not only in approaches to tissue replacement but also in the design and testing of antiarrhythmic drugs.This methodology has advanced to the point where induced human cardiomyocyte cell lines can now also be obtained from commercial sources or tissue banks.Initial studies with readily available iPSCs have generally confirmed that their behavioral characteristics accurately predict the behavior of beating cardiomyocytes in vivo.As a result,iPSCs can provide new ways to study arrhythmias and heart disease in general,accelerating the development of new,more effective antiarrhythmic drugs,clinical diagnoses,and personalized medical care.The focus on producing cardiomyocytes that can be used to replace damaged heart tissue has somewhat diverted interest in a host of other applications.This manuscript is intended to provide non-specialists with a brief introduction and overview of the research carried out in the field of heart rhythm disorders. | Steven B Karch Vittorio Fineschi Pietro Francia Matteo Scopetti Martina Padovano Federico Manetti Alessandro Santurro Paola Frati Massimo Volpe | 2021 | World Journal of Stem Cells2021，13，5： | 0 |
您所在的机构暂未开通此部分的功能，请联系管理员